Refresh
EBOS Group - FY23 Result — Back to Reality
FY23 was another strong period for EBOS Group (EBO) with EPS +15%, which rounds off an impressive three-years of growth (FY20–FY23 EPS CAGR of +14%).
Forsyth Barr
264 Views
EBOS Group - FY23 Preview — Checking Up
We expect EBOS Group (EBO) to report a solid FY23 result on Wednesday, 23 August. Similar to recent results, we expect a continuation of robust...
Forsyth Barr
154 Views
EBOS Group: Back to the Core
EBOS Group (EBO) has been dealt a material and surprising blow with the loss of its Chemist Warehouse (CW) Pharmaceutical supply contract from 1...
Forsyth Barr
276 Views
EBOS Group (EBO): Chemist Warehouse Update – Sigma Wins Both Contracts
EBOS Group’s (EBO), largest competitor Sigma (SIG.ASX) has confirmed it has signed a binding term sheet with Chemist Warehouse (CW) for both the...
Forsyth Barr
266 Views
EBOS Group: 1H23 Result — In the Waiting Room
EBOS Group (EBO) reported a strong 1H23 result in-line with our expectations (ahead of consensus) showcasing +30% NPAT growth versus 1H22; While we...
Forsyth Barr
222 Views